Document text
Principal Investigator: Ayyalusamy Ramamoorthy
Organization: FLORIDA STATE UNIVERSITY
Fiscal Year: 2024
Award: $354,275
Funding agency: National Institute of Diabetes and Digestive and Kidney Diseases
The accumulation of particular proteins into long fibrillar aggregates known as amyloids is a common feature of
many devastating aging-related pathologies. In type II diabetes mellitus, the main constituent of these
aggregates is Islet Amyloid Polypeptide (IAPP, also known as amylin). Like many other amyloidogenic
proteins, the aggregation of IAPP has been linked to cellular dysfunction and death. However, the mechanism
by which IAPP aggregates form and how this aggregation is linked to cell death remain mysterious. To help
reduce this gap, we propose to characterize the oligomeric intermediates of human-IAPP formed in solution, in
presence of metals (such as zinc and copper), and in lipid-membrane via three specific aims. 1) In Aim 1, we
propose to characterize the intermediates formed by human-IAPP at atomic resolution by NMR spectroscopy.
The identified oligomeric intermediates will be tested for cell toxicity and the structural models derived from
NMR constraints will be used to evaluate the mechanism and efficiency of amyloid inhibitors. 2) Since a
possible genetic link between zinc regulation and type II diabetes has been discovered, we will characterize
zinc-IAPP adducts by cell toxicity, NMR and other biophysical experiments in Aim 2. Mutants of oxidized and
reduced forms of human-IAPP will be used to probe the metal binding sites, and isothermal titration
experiments will be used to measure the metal binding affinities to different amyloid species. In addition, the
non-fibril forming and non-toxic rat-IAPP and pramlintide (trade name symlin approved by FDA for use by both
type 1 and type 2 diabetic patients) will be used as controls. 3) To gain insight into the lipid-membrane assisted
hIAPP aggregation and the mechanism by which hIAPP disrupts the lipid-membrane, we propose to
characterize the role of lipid membrane by a variety of biophysical techniques (including high-speed atomic
force microscopy), and stabilize hIAPP oligomeric intermediates using lipid-nanodisc technology and solve the
high-resolution structure of oligomers by a combination of solid-state and solution NMR techniques. These
high-resolution structures will aid in the development of drugs to stop beta-cell death.
Terms: <AD dementia><Acceleration><Adult-Onset Diabetes Mellitus><Affect><Affinity><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Amyloid><Amyloid Substance><Amyloid fibers><Atomic Force Microscopy><Autoregulation><Basic Research><Basic Science><Beta Cell><Beta Sheet><Binding><Biophysics><Calcium><Cell Body><Cell Death><Cell Membrane Lipids><Cell Nucleus><Cell membrane><Cells><Cellular Membrane><Cessation of life><Chaperone><Characteristics><Chemicals><Clinical Research><Clinical Study><Common Rat Strains><Copper><Cu element><Cytoplasmic Membrane><Death><Degenerative Disorder><Deposit><Deposition><Diabetes Mellitus><Disease><Disease Progression><Disorder><Dysfunction><FDA approved><Fiber><Force Microscopy><Functional disorder><Generalized Growth><Genetic><Genetic Alteration><Genetic Change><Genetic defect><Growth><Homeostasis><Hormone secretion><Human><Human Genome><Humulin R><Individual><Insulin><Insulin Cell><Insulin Resistance><Insulin Secreting Cell><Insulinoma amyloid peptide><Investigation><Islet Cell><Ketosis-Resistant Diabetes Mellitus><Kinetics><Link><Lipids><Maps><Maturity-Onset Diabetes Mellitus><Measurement><Measures><Membrane><Membrane Lipids><Metal Binding Site><Metals><Minority><Modern Man><Molecular><Molecular Chaperones><Molecular Interaction><Monitor><Multidimensional NMR Techniques><Mutation><NIDDM><NMR Spectrometer><NMR Spectroscopy><Names><Nature><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Nuclear><Nucleus><Outcome><Paralysis Agitans><Parkinson><Parkinson Disease><Pathologic><Pathology><Pathway interactions><Pattern><Physiological Homeostasis><Physiopathology><Plasma Membrane><Play><Population><Pramlintide><Primary Parkinsonism><Primary Senile Degenerative Dementia><Process><Proteins><Rat><Rats Mammals><Rattus><Regular Insulin><Regulation><Resolution><Risk Factors><Role><SSNMR><Scanning Force Microscopy><Secretory Granules><Secretory Vesicles><Slow-Onset Diabetes Mellitus><Speed><Stable Diabetes Mellitus><Structural Models><Structure><Survival Rate><T2 DM><T2D><T2DM><Techniques><Testing><Time><Tissue Growth><Titrations><Toxic effect><Toxicities><Type 2 Diabetes Mellitus><Type 2 diabetes><Type 2 diabetic><Type II Diabetes Mellitus><Type II diabetes><Type II diabetic><Zinc><Zn element><aberrant folded protein><aberrant folded proteins><abnormal folded protein><abnormal folded proteins><adduct><adult onset diabetes><aging associated><aging related><amlintide><amylin><amyloid assembly><amyloid formation><amyloidogenesis><beta pleated sheet><biophysical approaches><biophysical foundation><biophysical methodology><biophysical methods><biophysical principles><biophysical sciences><biophysical techniques><brain amyloidogenesis><cytotoxic><degenerative condition><degenerative disease><design><designing><diabetes><diabetes associated peptide><diabetic><diabetic patient><drug development><experiment><experimental research><experimental study><experiments><genome mutation><glucose metabolism><hormonal secretion><human whole genome><inhibitor><insight><insoluble aggregate><insoluble fiber><insulin resistant><insulin tolerance><insulinoma amyloid polypeptide><islet amyloid polypeptide><ketosis resistant diabetes><maturity onset diabetes><membrane structure><misfolded protein><misfolded proteins><multidimensional NMR><multidimensional nuclear magnetic resonance><multidimensional nuclear magnetic resonance techniques><mutant><name><named><naming><nanodisc technology><nanodisk><necrocytosis><non-diabetic><nondiabetic><nuclear magnetic resonance spectroscopy><ontogeny><overexpress><overexpression><pancreatic amylin><pathophysiology><pathway><plasmalemma><primary degenerative dementia><protein aggregate><protein aggregation><proteotoxic protein><proteotoxin><resolutions><senile dementia of the Alzheimer type><social role><solid state><solid state NMR><solid state nuclear magnetic resonance><type 2 DM><type II DM><type two diabetes><β-Sheet><β-cell><β-cells><β-pleated sheet><βCell>